Archives
-
In Vitro Drug Response: Viability Versus Cell Death
2026-08-25
Hannah R. Schwartz’s dissertation examines a common interpretive problem in cancer pharmacology: relative viability and fractional viability are often treated as interchangeable despite measuring different biological outcomes. Its central finding is that drug-induced growth inhibition and cell death usually occur together, but their magnitudes and timing can differ, supporting paired and time-aware in vitro response analysis.
-
MG-132: From Proteasome Stress to Translational Insight
2026-08-25
MG-132 is more than a cytotoxicity reagent: used with appropriate controls, it can connect proteasome-dependent proteostasis to ubiquitin-regulated chromatin biology, cell-cycle decisions, and translational biomarker strategy.
-
Diuron-Induced Acute Kidney Injury: JAK2/STAT1 Insights
2026-08-24
The reference study combines network toxicology, molecular docking, transcriptomic validation, and HK-2 cell experiments to investigate how Diuron may cause acute kidney injury. Its results prioritize JAK2/STAT1 signaling as a mechanistic axis and provide a structured framework for connecting computational toxicology predictions with experimentally observed renal-cell injury.
-
Cabazitaxel (XRP6258): Practical Assay Guide
2026-08-24
Cabazitaxel (XRP6258, SKU B2157) is a semi-synthetic taxane derivative for studying antiproliferative responses and microtubule dynamics disruption, including models containing P-glycoprotein-expressing chemotherapy-resistant cells. It is suitable for carefully controlled DMSO- or ethanol-based workflows, but is insoluble in water and should not be placed into aqueous assays or stored as a solution long term.
-
Metronidazole: OAT3 and Anaerobe Research Guide
2026-08-23
Metronidazole supports two complementary research workflows: concentration-controlled OAT3 inhibition for transporter and drug-drug interaction studies, and anaerobic bacteria or protozoa treatment research. This guide translates its quantified transporter activity, formulation data, and antimicrobial utility into practical assay setup, optimization, and troubleshooting decisions.
-
EPZ5676: Practical DOT1L Inhibitor Workflows
2026-08-22
EPZ5676 is a highly selective DOT1L inhibitor for connecting SAM-pocket inhibition with H3K79 methylation and leukemia-cell phenotypes. This workflow-focused guide covers solvent preparation, dose-response design, orthogonal target-engagement assays, and troubleshooting for MLL-rearranged models.
-
CLCC1 and Herpesvirus Nuclear Egress
2026-08-22
A 2024 bioRxiv preprint identifies the host protein CLCC1 as an essential factor in the membrane-fusion step of herpesvirus nuclear egress. Genetic disruption of CLCC1 causes perinuclear vesicle accumulation, impaired capsid release, reduced viral titers, and defects in nuclear pore complex insertion, connecting viral egress with broader nuclear-envelope biology.
-
Streptavidin – Cy5 Workflows for Breast Cancer Research
2026-08-21
Streptavidin – Cy5 converts biotinylated antibodies, probes, and nucleic acids into a sensitive far-red readout for tissue imaging and cell analysis. This guide connects practical staining workflows with the USP42–JNK/p38 apoptosis findings, while emphasizing assay design, controls, and troubleshooting.
-
Mouse Neutrophil Cell Isolation Kit for Tumor Studies
2026-08-20
Build activation-conscious mouse neutrophil preparations for tumor immunology, nanovaccine testing, and functional co-culture assays. This column-free negative-selection workflow combines speed, target-cell preservation, and reported purity above 95%.
-
Entecavir-Associated Thrombocytopenia: Case Analysis
2026-08-20
This case report identifies a delayed, severe thrombocytopenic reaction after Entecavir exposure in a patient with chronic hepatitis B, extending the limited clinical evidence beyond previously described immediate responses. Its main practical implication is the need for regular platelet monitoring and preservation of antiviral coverage when serious hematologic toxicity is suspected.
-
Biotin-tyramide for Spatial Signal Amplification
2026-08-19
Biotin-tyramide converts HRP activity into highly localized biotin deposition for sensitive IHC and ISH, while preserving spatial information in fixed specimens. This guide connects practical TSA optimization with the RAB proximity map study, showing how amplified imaging can validate candidate trafficking relationships without being mistaken for direct interaction evidence.
-
CTP Solution for High-Fidelity mRNA Workflows
2026-08-19
Build more consistent IVT and RNA amplification workflows with a high-purity, RNase-free CTP stock designed for precise nucleotide control. This guide connects CTP handling to p21 mRNA–LNP research while separating reagent selection from downstream formulation and biological validation.
-
NHS-Biotin for Protein Labeling Workflows
2026-08-18
NHS-Biotin enables efficient amine-reactive labeling of antibodies, proteins, and intracellular targets for streptavidin-based detection or purification. This practical guide connects a reproducible labeling workflow with emerging nanobody multimerization assays while emphasizing controls, compatibility, and troubleshooting.
-
GLP-1 (9-36) amide Assay Workflow Guide
2026-08-18
Use GLP-1 (9-36) amide as a pharmacological probe to separate GLP-1 receptor-dependent cAMP signaling from receptor cross-talk and assay artifacts. This workflow combines careful peptide handling, FRET-compatible experimental design, comparative controls, and troubleshooting for metabolic and type 2 diabetes research.
-
DED Assembly Mechanisms in Death-Receptor Apoptosis
2026-08-17
The reference study resolves how FADD, procaspase-8, and cFLIP assemble through death-effector domains to tune apoptosis, survival, and necroptosis. By combining X-ray crystallography, cryo-EM, and structure-guided mutagenesis, it provides an atomic framework for interpreting caspase-8 activation and for designing mechanistically controlled follow-up experiments.